Pulmonary Cell News Volume 14.10 | May 29 2025

    0
    2







    2025-05-29 | PULCN 14.10


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 14.10 – 29 May, 2025
    TOP STORY

    Molecular Determinants of Sotorasib Clinical Efficacy in KRASG12C-Mutated Non-Small-Cell Lung Cancer

    The authors reported one of the largest integrated analyses to date of sotorasib clinical efficacy biomarkers from the Phase II CodeBreaK 100 and Phase III CodeBreaK 200 studies.
    [Nature Medicine]

    Full Article
    Standardize Your Spheroid Production With AggreWellâ„¢ Microwell Plates
    PUBLICATIONSListed by the impact factor of the journal

    Alveolar Epithelial and Vascular CXCR2 Mediates Transcytosis of CXCL1 in Inflamed Lungs

    Using conditional endothelial and epithelial CXCR2 knockout mice, scientists demonstrated that selective CXCR2 deletion in either compartment impairs neutrophil recruitment into the lung during bacterial pneumonia and reduces bacterial clearance.
    [Nature Communications]

    Full Article

    Single-Cell Profiling Demonstrates the Combined Effect of Wheeze Phenotype and Infant Viral Infection on Airway Epithelial Development

    Researchers characterized nasal airway epithelial cell (NAEC) developmental phenotypes from children aged two to three years in an a priori designed nested birth cohort from four mutually exclusive groups of wheezers/nonwheezers and respiratory syncytial virus–infected/uninfected in the first year of life.
    [Science Advances]

    Full Article

    ANT1 Deficiency Impairs Macrophage Metabolism and Migration, Protecting against Emphysema in COPD

    Investigators demonstrated that human alveolar macrophages from patients with moderate COPD have reduced ANT1 expression while macrophages from very severe COPD have elevated ANT1 compared to normal control subjects.
    [American Journal of Respiratory Cell and Molecular Biology]

    Abstract

    ITIH4 Attenuates Acute Lung Injury by Fe-Containing Particulate Matter in Mice via Hippo Pathway in Type II Alveolar Epithelial Cells

    Scientists investigated the effects of recombinant inter-alpha-trypsin inhibitor heavy chain H4 (ITIH4) against acute lung injury in C57BL/6JNarl and B6.Sftpc-CreERT2;Ai14(RCL-tdT)-D mice exposed to Fe-containing particulate matter.
    [Respiratory Research]

    Full Article

    Expression of Membrane Targets for Therapeutics in RET-Positive Non–Small Cell Lung Cancer

    In this cohort study of 93 RET+ NSCLC samples and 112 RET wild-type controls, mesenchymal epithelial transition factor receptor immunohistochemistry expression was significantly enriched in RET+ NSCLC.
    [JAMA]

    Abstract

    RNF20 Links the DNA Damage Response and Metabolic Rewiring in Lung Cancer through HIF1α

    Investigators showed that an RNF20-HIF1α axis links the DNA damage response and metabolic reprogramming in lung cancer.
    [Nature Communications]

    Full Article

    FOXA2 Promotes Metastatic Competence in Small Cell Lung Cancer

    The authors compared gene expression in small cell lung cancer (SCLC) patient samples who never experienced metastasis or relapse throughout their clinical course, versus primary SCLC patient samples from more typical patients who had metastatic disease at diagnosis.
    [Nature Communications]

    Full Article

    Phase Separation of RXRγ Drives Tumor Chemoresistance and Represents a Therapeutic Target for Small-Cell Lung Cancer

    Investigators identified retinoid X receptor γ (RXRγ) as a key driver in the progression of small-cell lung cancer from chemosensitivity to chemoresistance.
    [Proceedings of The National Academy of Sciences of The United States of America]

    Abstract
    REVIEWS

    Epithelial Damage and Aging: The Perfect Storm

    The authors highlight how, with increasing age, the alveolar epithelium becomes vulnerable to exogenous insults.
    [Thorax]

    Full Article
    INDUSTRY AND POLICY NEWS

    Cleveland Clinic Receives $5 Million Grant to Lead Biorepository Coordinating Center for Cystic Fibrosis Lung Transplant Consortium

    Cleveland Clinic has been awarded a $5 million grant from the Cystic Fibrosis Foundation to continue its role as the Biorepository Coordinating Center for the Cystic Fibrosis Lung Transplant Consortium until 2030.
    [Cleveland Clinic]

    Press Release
    FEATURED EVENT

    26th Annual International Lung Cancer Congress

    July 25-26, 2025
    Huntington Beach, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Clinical Research Fellow – Pulmonary Tuberculosis

    University of Leicester – Leicester, England, United Kingdom

    Post Doctoral Fellow – Internal Medicine, Pulmonary

    University of Cincinnati – Cincinnati, Ohio, United States

    PhD & Postdoctoral Positions – Lung Cancer

    3IA Côte d’Azur – Valbonne, France

    Postdoctoral Research Associate – Lung and Mammary Gland Morphogenesis

    Princeton University – Princeton, New Jersey, United States

    PhD Position – Respiratory Infection Transmission

    University of Newcastle – Callaghan, Australia

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2